Path: /researchers/thomas-arzberger
Title: Neuropathologist
Affiliation: Ludwig Maximilian University of Munich (LMU) — Center for Neuropathology and Prion Research
Location: Munich, Germany
Areas: Tau pathology, Alzheimer's disease, Neurofibrillary tangle staging, 4R-tauopathies
Thomas Arzberger is a German neuropathologist known for his work on the staging and classification of Alzheimer's disease neurofibrillary pathology. In collaboration with Heiko Braak and Kelly Del Tredici, he helped develop the influential Braak staging system for neurofibrillary tangle distribution, which remains a cornerstone of AD diagnosis and research classification[1].
His technical expertise in immunocytochemistry and paraffin section analysis enabled precise mapping of tau pathology progression through the brain, from early entorhinal involvement to advanced neocortical stages. This work provided the histological foundation for understanding the spread of tau pathology in Alzheimer's disease and related tauopathies.
Arzberger's most cited work established the systematic staging protocol for Alzheimer's disease-associated neurofibrillary pathology:
This staging system correlated clinical symptoms with pathological burden, enabling clinicopathological correlation studies and providing a framework for biomarker validation.
His methodological innovations include:
Beyond Alzheimer's disease, Arzberger has contributed to the understanding of:
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006[1:1]. PMID:16855773
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-type neurofibrillary tangles in the human brain. Acta Neuropathol. 2006[2]. PMID:16783324
Braak H, Thal DR, Arzberger T, et al. stages of Alzheimer-related lesions. Acta Neuropathol. 2011[3]. PMID:21789521
Arzberger works at the Center for Neuropathology and Prion Research at LMU Munich, one of Germany's leading neurodegenerative disease research centers. LMU Munich operates within the Munich Cluster for Systems Neurology (SyNergy), a interdisciplinary research network focused on neurodegenerative disease mechanisms.
The center's location within Munich's neuroscience ecosystem provides access to:
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica. 2006. ↩︎ ↩︎
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-type neurofibrillary tangles in the human brain. Acta Neuropathologica. 2006. ↩︎
Braak H, Thal DR, Arzberger T, et al. Stages of Alzheimer-related lesions. Acta Neuropathologica. 2011. ↩︎